
|Videos|November 9, 2021
Hormone therapy, osteoporosis treatments and hybrid health care with Risa Kagan, MD
Author(s)Lindsey Carr, Editor
We caught up with Risa Kagan, MD, at the North American Menopause Society's 2021 Annual Meeting to hear about her role on the Scientific Planning Committee and this year's takeaways.
Advertisement
Risa Kagan, MD, FACOG, is an ob/gyn and clinical professor at the University of California San Francisco. She currently serves on the NAMS Board of Trustees.
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
CDC: 15% of US women report drinking alcohol during pregnancy
2
CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition
3
GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients
4
CMS' obstetric G-codes cause confusion, perimenopause uncertainty, Zuranolone real-world data
5





